|
|
Taiwan Academic Institutional Repository >
Browse by Author
|
"wu y l"
Showing items 256-265 of 372 (38 Page(s) Totally)
<< < 21 22 23 24 25 26 27 28 29 30 > >>
View [10|25|50] records per page
| 國立臺灣大學 |
2015 |
Efficacy by blind independent central review (BICR): Post hoc analyses of the phase III, multicentre, randomised IPASS study of 1st-line gefitinib (G) vs carboplatin/paclitaxel (C/P) in Asian patients (pts) with EGFR mutation-positive advanced NSCLC
|
Mok, T.; Saijo, N.; Thongprasert, S.; Yang, J. C. -H.; Wu, Y. -L.; Young, H.; Haddad, V.; Jiang, H.; Fukuoka, M.; 楊志新 |
| 國立臺灣大學 |
2015 |
Afatinib (A) versus chemotherapy (CT) for EGFR mutation-positive NSCLC patients (pts) aged >= 65 years: Subgroup analyses of LUX-Lung 3 (LL3) and LUX-Lung 6 (LL6)
|
Wu, Y. -L.; Sequist, L. V.; Geater, S. L.; Orlov, S.; Lee, K. H.; Tsai, C. -M.; Kato, T.; Kiura, K.; Barrios, C. H.; Schuler, M.; Hirsh, V.; Yamamoto, N.; O'Byrne, K.; Mok, T.; Massey, D.; Maerten, A.; Yang, J. C. -H.; 楊志新 |
| 臺大學術典藏 |
2015 |
A KRAS mutation status-stratified randomized phase II trial of gemcitabine and oxaliplatin alone or in combination with cetuximab in advanced biliary tract cancer
|
on behalf of the Taiwan Cooperative Oncology Group; Wei T.-C.; Shan Y.S.; Chao Y.; Chen L.-T.; Chin Y.-H.; Chung T.-R.; Yu W.-L.; Lee M.-H.; Lin L.-F.; Lin P.-C.; Wu Y.-L.; Wang H.-L.; Lu L.-J.; Chen S.-Y.; Wu C.-C.; Chang J.Y.; Yu M.S.; Yang Y.; Hsieh R.K.; Chiu C.F.; Rau K.M.; Lee K.D.; Shiah H.S.; Chang I.C.; Bai L.Y.; Huang S.F.; Tsou H.H.; Tsai C.S.; Chiang N.J.; CHIH-HUNG HSU; Chen J.S.; Chen J.S.;Chih-Hung Hsu;Chiang N.J.;Tsai C.S.;Tsou H.H.;Huang S.F.;Bai L.Y.;Chang I.C.;Shiah H.S.;Ho C.L.;Yen C.J.;Lee K.D.;Chiu C.F.;Rau K.M.;Yu M.S.;Yang Y.;Hsieh R.K.;Chang J.Y.;Shan Y.S.;Chao Y.;Chen L.-T.;Chin Y.-H.;Chung T.-R.;Yu W.-L.;Lee M.-H.;Lin L.-F.;Lin P.-C.;Wu Y.-L.;Wang H.-L.;Lu L.-J.;Chen S.-Y.;Wu C.-C.;Wei T.-C.;On Behalf Of The Taiwan Cooperative Oncology Group; Yen C.J.; Ho C.L. |
| 臺大學術典藏 |
2015 |
Monotherapy Administration of Sorafenib in Patients with Non-Small Cell Lung Cancer (MISSION) Trial: A Phase III, Multicenter, Placebo-Controlled Trial of Sorafenib in Patients with Relapsed or Refractory Predominantly Nonsquamous Non-Small-Cell Lung Cancer after 2 or 3 Previous Treatment Regimens
|
Mok T.S.;Smit E.F;Pen? C;Ong T.J;Schmelter T;Sun Y;Ar?n O;Juh?sz E;Novello S;Wu Y.-L;Seto T;Wakelee H.A;Chih-Hsin Yang;De Marinis F;Zhang L;Hirsh V;Paz-Ares L; Paz-Ares L; Hirsh V; Zhang L; De Marinis F; CHIH-HSIN YANG; Wakelee H.A; Seto T; Wu Y.-L; Novello S; Juhász E; Arén O; Sun Y; Schmelter T; Ong T.J; Penã C; Smit E.F; Mok T.S. |
| 國立交通大學 |
2014-12-08T15:11:25Z |
Ratio of Wnt3a to BMP4 doses is critical to their synergistic effects on proliferation of differentiating mouse embryonic stem cells
|
Lin, S. -Y.; Chen, C. -L.; Wu, Y. -L.; Yang, Y. -C.; Hwu, Y. -M. |
| 佛光大學 |
2014-04 |
Use mobile apps to teach English
|
Wu, Ya-Li;Wu, Y. L.; 吳雅莉 |
| 佛光大學 |
2014-03 |
Use mobile apps in English classroom
|
Wu, Ya-Li;Wu, Y. L.; 吳雅莉 |
| 佛光大學 |
2014-02 |
The use of technology and international students' academic acculturation
|
Wu, Ya-Li;Wu, Y. L.; 吳雅莉 |
| 國立臺灣科技大學 |
2014 |
Characterization and evaluation of prepared Fe2O3/Al2O3 oxygen carriers for chemical looping process
|
Chiu, P.-C.;Ku, Y.;Wu, Y.-L.;Wu, H.-C.;Kuo, Y.-L.;Tseng, Y.-H. |
| 國立臺灣科技大學 |
2014 |
Gaze direction estimation using support vector machine with active appearance model
|
Wu, Y.-L.;Yeh, C.-T.;Hung, W.-C.;Tang, C.-Y. |
Showing items 256-265 of 372 (38 Page(s) Totally)
<< < 21 22 23 24 25 26 27 28 29 30 > >>
View [10|25|50] records per page
|
